AKBA
Akebia Therapeutics, Inc.
0.8148$
-6.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | 262.6 | 15.9 | 11.5 | 10.0 | 4.1 | 2.3 | 2.5 | 2.1 | 3.1 | 4.1 | 2.0 | 1.4 | 2.2 | 2.8 | 5.5 | 1.2 | 1.4 | 2.0 | 2.8 | 2.4 | 1.9 | 0.6 | 0.2 | 0.2 | 0.4 | 0.4 | 0.9 | 1.1 | 1.2 | 2.0 | 1.2 | 1.6 | 2.6 | 2.5 | 4.8 | 3.3 | 1.8 | 1.6 | 1.4 | |
| 3.4 | 5.9 | 11.6 | 10.3 | 9.3 | 6.1 | 2.3 | 3.4 | 3.5 | 1.0 | 1.7 | 1.1 | 1.0 | 1.9 | 2.5 | 5.0 | 1.1 | 1.6 | 2.4 | 3.5 | 3.7 | 5.5 | 5.0 | 1.1 | 4.2 | 20.4 | – | – | – | – | – | – | – | – | 18.7 | 33.4 | 17.8 | 13.0 | 13.7 | 11.9 | |
| – | 140.6 | 12.0 | 9.1 | 9.1 | 3.7 | 1.5 | 1.8 | 1.4 | 2.7 | 4.0 | 1.7 | 1.1 | 2.0 | 2.7 | 5.0 | 0.9 | 1.0 | 1.4 | 2.1 | 1.9 | 1.7 | 0.3 | 0.1 | -0.1 | 0.3 | 0.4 | 0.8 | 1.1 | 1.2 | 1.9 | 1.2 | 1.7 | 2.6 | 2.2 | 4.4 | 2.8 | 1.2 | 1.1 | 0.9 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 22.9 | – | – | – | 132.8 | 53.4 | 77.0 | – | 82.9 | 81.0 | 29.5 | 13.4 | – | – | |
| – | 7.3 | 12.8 | 7.3 | 16.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 23.0 | 6.3 | 6.2 | 7.4 | |
| -18.4% | 13.7% | 7.8% | 13.7% | 5.9% | -8.0% | -14.8% | -14.7% | -8.2% | -15.4% | -22.7% | -47.1% | -53.1% | -35.1% | -21.9% | -7.3% | -48.0% | -27.3% | -17.6% | -31.4% | -43.9% | -62.6% | -157.7% | -257.3% | -138.3% | -68.7% | -66.8% | -20.2% | -36.6% | -10.2% | -6.9% | -18.6% | -14.1% | -9.8% | -7.6% | -0.3% | 4.3% | 15.9% | 16.1% | 13.6% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | -7,443.0% | -594.6% | -230.9% | -112.5% | -29.7% | -14.4% | -16.6% | -15.8% | -1.9% | 22.6% | 48.6% | 64.7% | 65.0% | 67.6% | 26.3% | 21.2% | 12.1% | -2.8% | 35.0% | 38.4% | 36.3% | 40.5% | 66.9% | 59.3% | 70.8% | 72.6% | 63.7% | 72.9% | 61.9% | 69.7% | 72.7% | 74.2% | 71.6% | 72.7% | 74.4% | 78.8% | 83.3% | 80.9% | 79.5% | |
| – | -8,889.9% | -693.7% | -277.6% | -140.3% | -44.9% | -29.3% | -32.7% | -32.6% | -85.8% | -97.9% | -88.5% | -86.5% | -85.5% | -76.8% | -112.8% | -125.2% | -127.5% | -147.5% | -129.7% | -135.1% | -125.0% | -116.7% | -49.1% | -47.6% | -27.8% | -17.9% | -45.6% | -27.9% | -23.8% | -19.0% | -20.2% | -20.5% | -31.5% | -11.9% | 0.4% | 7.9% | 9.9% | 2.3% | -6.9% | |
| – | -8,843.5% | -689.7% | -275.4% | -137.8% | -43.2% | -27.5% | -30.6% | -30.3% | -82.7% | -94.2% | -85.5% | -84.1% | -83.5% | -76.4% | -113.4% | -126.9% | -129.9% | -151.4% | -135.0% | -142.0% | -133.3% | -124.3% | -55.1% | -53.3% | -32.4% | -21.9% | -49.8% | -31.0% | -26.7% | -23.0% | -23.2% | -27.1% | -43.3% | -24.5% | -17.9% | -7.1% | -2.3% | -8.8% | -13.5% | |
| – | 3,599.0% | 124.8% | 157.9% | 59.3% | -32.5% | -33.7% | -37.5% | -17.6% | -47.7% | -93.1% | -93.4% | -75.7% | -78.8% | -61.0% | -40.1% | -55.8% | -37.5% | -35.5% | -86.7% | -105.1% | -119.5% | -92.3% | -58.2% | -27.6% | -25.1% | -25.6% | -17.4% | -39.1% | -12.0% | -13.5% | -22.4% | -22.7% | -25.4% | -18.9% | -1.3% | 14.3% | 28.6% | 25.8% | 18.4% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -116.9% | -199.3% | -504.6% | -246.0% | -127.2% | -64.5% | -28.3% | -41.2% | -50.0% | -27.0% | -39.0% | -47.2% | -58.5% | -70.8% | -67.6% | -104.1% | -123.0% | -154.9% | -183.4% | -171.5% | -218.1% | -381.1% | -1,052.5% | -260.6% | -1,132.8% | -1,809.2% | – | – | – | – | – | – | – | – | -184.3% | -124.8% | -38.2% | -16.4% | -74.9% | -118.6% | |
| -69.6% | -45.2% | -59.6% | -41.6% | -37.5% | -21.1% | -12.6% | -16.5% | -17.6% | -17.3% | -24.8% | -29.8% | -34.4% | -36.3% | -34.0% | -51.7% | -57.8% | -59.5% | -62.4% | -49.0% | -49.7% | -53.3% | -51.3% | -31.1% | -36.0% | -26.6% | -21.3% | -39.3% | -25.6% | -21.5% | -19.1% | -18.4% | -22.2% | -31.5% | -14.6% | -10.6% | -4.4% | -1.4% | -5.7% | -8.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -26 | -187 | -87 | -125 | -90 | -69 | -157 | -164 | -162 | -90 | -27 | -82 | -118 | -65 | -33 | -162 | -85 | -125 | -151 | -145 | -104 | -46 | -72 | -41 | -75 | -20 | -0.7 | -5.6 | 0.9 | -3.8 | -6.7 | 5.7 | 12 | -3.5 | -61 | -85 | -114 | -133 | -114 | -106 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.2 | – | – | – | -2.5 | 1.4 | 3.2 | – | -12.8 | -7.7 | -5.4 | -6.1 | – | – | |
| 59.6% | 22.7% | 11.8% | 16.9% | 29.5% | 32.8% | 44.5% | 40.1% | 35.3% | 63.8% | 63.6% | 63.1% | 58.8% | 51.2% | 50.3% | 49.7% | 47.0% | 38.4% | 34.0% | 28.5% | 22.8% | 14.0% | 4.9% | 11.9% | 3.2% | 1.5% | -5.2% | -10.6% | -16.8% | -12.7% | -12.1% | -15.3% | -24.3% | -22.3% | 7.9% | 8.5% | 11.4% | 8.7% | 7.6% | 7.2% | |
| 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.3 | 0.4 | 0.5 | 0.6 | 0.8 | 1.4 | 3.9 | 1.6 | 5.1 | 13.5 | – | – | – | – | – | – | – | – | 2.1 | 1.8 | 1.3 | 1.6 | 1.8 | 2.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -3.11 | -3.50 | -3.99 | -3.44 | -2.71 | -1.58 | -1.15 | -1.20 | -1.25 | -1.47 | -1.89 | -2.07 | -2.30 | -2.34 | -2.09 | -2.82 | -2.73 | -2.64 | -2.55 | -1.86 | -1.72 | -1.61 | -1.53 | -0.85 | -0.85 | -0.51 | -0.32 | -0.53 | -0.32 | -0.27 | -0.21 | -0.19 | -0.22 | -0.32 | -0.19 | -0.13 | -0.06 | -0.02 | -0.08 | -0.11 | |
| 0.00 | 0.04 | 0.58 | 1.25 | 1.96 | 3.66 | 4.18 | 3.93 | 4.12 | 1.78 | 2.00 | 2.42 | 2.74 | 2.81 | 2.73 | 2.48 | 2.15 | 2.04 | 1.68 | 1.38 | 1.21 | 1.21 | 1.23 | 1.55 | 1.60 | 1.59 | 1.46 | 1.07 | 1.03 | 1.02 | 0.91 | 0.83 | 0.81 | 0.73 | 0.77 | 0.75 | 0.82 | 0.89 | 0.87 | 0.81 | |
| 2.66 | 1.76 | 0.79 | 1.40 | 2.13 | 2.45 | 4.05 | 2.92 | 2.50 | 5.44 | 4.84 | 4.39 | 3.93 | 3.31 | 3.09 | 2.70 | 2.22 | 1.71 | 1.39 | 1.08 | 0.79 | 0.42 | 0.15 | 0.33 | 0.08 | 0.03 | -0.08 | -0.14 | -0.21 | -0.16 | -0.13 | -0.16 | -0.24 | -0.22 | 0.10 | 0.11 | 0.15 | 0.12 | 0.10 | 0.09 | |
| -1.67 | 1.43 | 0.72 | 1.97 | 1.16 | -1.19 | -1.41 | -1.47 | -0.73 | -0.85 | -1.87 | -2.26 | -2.07 | -2.21 | -1.67 | -1.00 | -1.20 | -0.76 | -0.60 | -1.19 | -1.27 | -1.44 | -1.14 | -0.90 | -0.44 | -0.40 | -0.37 | -0.19 | -0.40 | -0.12 | -0.12 | -0.19 | -0.18 | -0.19 | -0.14 | -0.01 | 0.12 | 0.25 | 0.22 | 0.15 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.